Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2023 21:00 ET | Source: Vaccinex, Inc.

Vaccinex Announces Pricing of $9.6 Million Public Offering

ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
April 27, 2022 09:25 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference

BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
June 08, 2021 10:00 ET | Source: Verb Technology Company, Inc.

VERB Management to Discuss Company’s Application Solutions for the Growing Livestream Ecommerce Market at A.G.P.’s Tech Talk Webinar on Thursday, June 10, 2021, at 11:00 a.m. ET

Microsoft Outlook Integration of VERB’s interactive video sales technology set for commercial release in mid-June among Company’s leading revenue catalysts Company reported Q1 2021 SaaS recurring...
November 17, 2020 08:00 ET | Source: Entasis Therapeutics Holdings Inc.

Entasis Therapeutics to Participate in A.G.P.’s Virtual Healthcare Symposium

WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
July 27, 2020 09:30 ET | Source: Professional Diversity Network, Inc.

Professional Diversity Network Announces $2 Million Registered Direct Offering

CHICAGO, July 27, 2020 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (Nasdaq: IPDN), today announced it has entered into definitive agreements with institutional investors for the...